Falk Supplementation Schedule

Falk Supplementation Schedule

This is a detailed supplement schedule that includes Vitamin C, niacinamide, Vitamin E, B-Complex, etc. While there are no statistics that I know of for this treatment plan it appears to be a supercharged Hoffman plan. Its cure rate would clearly outperform orthodox treatments (as Hoffman's did and as the weaker Pauling/Cameron plan did), but does not appear strong enough to be a stand-alone plan. Rather, it would be wise to have a base alternative treatment plan (e.g. laetrile), and then add the Falk supplements to the base plan. As long as you are at it, you might as well add the rest of the Rath Cellular Solution supplements. See http://www.mnwelldir.org/docs/nutrition/diet.htm

Cancer and the Search for Selective Biochemical Inhibitors

by E.J. Hoffman
CRC Press LLC, P.O. Box 31225, Tampa, Florida 33631-3225 USA; 800-272-7737; fax 800-374-3401
Hardback, 560 pp., 1999, $139.95 + shipping

E.J. Hoffman has compiled a text from an extensive review of authoritative scientific literature on cancer and on botanicals. He presents this information in his book Cancer and the Search for Selective Biochemical Inhibitors in order to encourage research to identify substances that can inhibit cancer cell metabolic enzymes. The book includes what is known or currently presumed about the biochemistry of cancer, its biogenesis, and the role of viruses in cancer. Plant biochemistry, chemical taxonomy, the medicinal uses of fungi and of alkaloids found in plants form other chapters in the book.

Finding a way to rid the body of cancer cells without damaging normal cells has been a long-standing problem of chemical "warfare" against cancer. Hoffman explains that today's chemotherapy drugs or chemicals inhibit the action of enzymes, found in both cancerous and normal cells, that are used in DNA/RNA/protein synthesis. Instead of inhibiting protein synthesis, which kills or damages both kinds of cells, Hoffman suggests another route. Cancerous and normal cells differ in the way that they convert glucose into energy. Normal cells use oxygen to convert glucose or glycogen (the body's stored form of carbohydrate) into energy. Although cancer cells also carry out aerobic glycolysis, they primarily convert glucose anaerobically (without oxygen), resulting in the end product of lactic acid or lactate. Hoffman believes that phytochemicals or nontoxic substances, such as vitamins or minerals, that inhibit enzymes necessary for converting glucose to lactic acid "may be a promising avenue for noninvasive cancer treatment."

Hoffman proposes investigating biochemicals that block the action of lactate dehydrogenase, an enzyme needed to convert pyruvate into lactate, as one means of disrupting glycolysis and, thereby, destroying cancer cells. Cancer cells are not the only source of lactic acid or lactate in the body, however. Physical exercise can cause a build-up of lactic acid in muscles. Hoffman notes that medical folklore encourages exercise as a means of preventing cancer and comments that a survey of cancer incidence among athletes might provide interesting information. He speculates that increasing the amount of lactic acid in the body, through exercise or intake of Lactobacillus, might discourage anaerobic glycolysis, and thus suppress cancer.

Cancer and the Search for Selective Biochemical Inhibitors contains numerous appendices of literally hundreds of plants that are considered to have anti-cancer properties. Hoffman urges that "these plants or plant substances, or other substances, be investigated for their specific functions as enzyme inhibitors (or sometimes, as promoters or activators). In particular, the chemical classes or compounds themselves should be identified and further studied as to their particular role as enzyme inhibitors." He also suggests viewing carcinogenic substances found in plants as possible anti-cancer agents, saying "what is toxic or carcinogenic at one dosage level can be anticarcinogenic at another dosage level." Hoffman recognizes that some substances may affect more than one enzyme-catalyzed reaction, causing them to generate unexpected or unwanted mae effects, and suggests that lower dosage levels and frequency may minimize toxic effects.

In addition to lists of plants with anticancer effects, Cancer and the Search for Selective Biochemical Inhibitors includes information on other medicinal plants. These plants do not necessarily target cancer cell metabolism, but they may still be helpful in overcoming the disease. A compound from the shiitake mushroom, for example, has been approved as an anticancer treatment in Japan. The mushroom contains a compound that activates T-lymphocyte cells. Some fungi and fungal compounds kill the viruses that are considered necessary contributors (though "not sufficient to cause tumors") to cancer.

Cancer and the Search for Selective Biochemical Inhibitors succeeds as a textbook reference on the subject of cancer, its biochemistry, and some factors that promote and inhibit it. I found, however, that Hoffman's thesis concerning selective biochemical inhibitors gets overwhelmed by the volumes of repetitive lists and many digressions on subjects, such as hyperthermia and rabies, that have nothing specifically to do with his thesis.
Article copyright Townsend Letter for Doctors & Patients.
By Jule Klotter

Share this with your friends